EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rewiring Pyroptosis to Potentiate Cancer Immunotherapy via a Gasdermin D Agonist Bypassing Caspase‐3

Dan Zhao, Lingling Zhang, Yue Wen, Lianghui Cheng, Sidan Tian, Fanling Meng, Liang Luo iD

Advanced Science · 2026

DOI: 10.1002/advs.76655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Dan Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Nanomedicine, College of Life Science and Technology and Key Laboratory of Molecular Biophysics of the Minis…. Hauptthemen laut MEDLINE: Pyroptosis, Caspase 3, Immunotherapy, Phosphate-Binding Proteins. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Double First-class.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis holds great promise for evoking robust anti‐tumor immunity, but many pyroptosis induction strategies rely on caspase‐3 (Casp‐3) activation and face challenges of the immunosuppressive nature of apoptosis and the frequent silencing of gasdermin E (GSDME), a substrate of Casp‐3, in tumors. Here, we report a strategy to rewire the pyroptotic pathway by bypassing Casp‐3 to directly activate gasdermin D (GSDMD). We identify a small‐molecule agonist, (E)‐2,3‐diiodobut‐2‐ene‐1,4‐diol (DIBDO), which undergoes deiodination to release iodide ions upon activation by the tumor‐abundant nucleophile glutathione, thereby catalytically generating singlet oxygen and molecular iodine. This cascade induces oxidative damage that downregulates key mediators of caspase‐9 and caspase‐8 pathways, thereby down‐regulating Casp‐3 activation. This mechanism selectively triggers GSDMD‐mediated pyroptosis, provoking robust immunogenic cell death and inflammatory cytokine release to reconfigure the tumor immune microenvironment. In murine tumor models, DIBDO enhances tumor infiltration of cytotoxic T cells and synergizes with checkpoint blockade therapy to suppress both primary and distal tumors. It can also serve as an in situ or exogenous vaccine to elicit potent and durable antitumor immunity. This work presents a paradigm‐shifting approach to cancer immunotherapy by decoupling pyroptosis from Casp‐3 dependence, offering a promising avenue to expand the scope of immunogenic cell death‐based treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisCaspase 3ImmunotherapyPhosphate-Binding ProteinsIntracellular Signaling Peptides and ProteinsNeoplasmsAnimalsMiceGasderminsHumansFemale

Stichwörter der Autor:innen

bypassing Caspase3glutathione deplesionimmunotherapyoxidative stresspyroptosis

Substanzen

Caspase 3GasderminsPhosphate-Binding ProteinsIntracellular Signaling Peptides and ProteinsGsdmd protein, mouseCasp3 protein, mouse

Autor:innen und Institutionen

  • National Engineering Research Center for Nanomedicine, College of Life Science and Technology and Key Laboratory of Molecular Biophysics of the Ministry of Education, Huazhong University of Science and Technology, Wuhan…
  • Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Key Laboratory of Bioinformatics and Molecular Imaging, College of Life Science and Technology and Key Laboratory of Molecular Biophysics of the Ministry of Education, Huazhong University of Science and Technology…

ORCID-Profile: Liang Luo

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Double First-class
  • "Double First-class" Funds for Central Universities in Hubei

Zitieren

APA

Zhao, D., Zhang, L., Wen, Y., Cheng, L., Tian, S., Meng, F., & Luo, L. (2026). Rewiring Pyroptosis to Potentiate Cancer Immunotherapy via a Gasdermin D Agonist Bypassing Caspase‐3. Advanced Science. https://doi.org/10.1002/advs.76655

Vancouver

Zhao D, Zhang L, Wen Y, Cheng L, Tian S, Meng F, et al. Rewiring Pyroptosis to Potentiate Cancer Immunotherapy via a Gasdermin D Agonist Bypassing Caspase‐3. Advanced Science. 2026. doi:10.1002/advs.76655

BibTeX
@article{Zhao2026,
  author = {Zhao, Dan and Zhang, Lingling and Wen, Yue and Cheng, Lianghui and Tian, Sidan and Meng, Fanling and Luo, Liang},
  title = {Rewiring Pyroptosis to Potentiate Cancer Immunotherapy via a Gasdermin D Agonist Bypassing Caspase‐3},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76655}
}
Kostenlos starten →